THC Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
THC Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2010 to Q1 2024.
  • THC Therapeutics, Inc. Interest Expense for the quarter ending April 30, 2024 was $18.3K, a 4.64% decline year-over-year.
  • THC Therapeutics, Inc. Interest Expense for the twelve months ending April 30, 2024 was $77.6K, a 63.8% increase year-over-year.
  • THC Therapeutics, Inc. annual Interest Expense for 2023 was $79.6K, a 20.7% decline from 2022.
  • THC Therapeutics, Inc. annual Interest Expense for 2022 was $100K, a 81.8% decline from 2021.
  • THC Therapeutics, Inc. annual Interest Expense for 2021 was $552K, a 13.1% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $77.6K $18.3K -$892 -4.64% Feb 1, 2024 Apr 30, 2024 10-Q 2024-11-13
Q4 2023 $78.4K $19.7K -$396 -1.97% Nov 1, 2023 Jan 31, 2024 10-Q 2024-09-05
Q3 2023 $78.8K $19.4K -$737 -3.66% Aug 1, 2023 Oct 31, 2023 10-Q 2024-08-09
Q2 2023 $79.6K $20.2K +$32.2K May 1, 2023 Jul 31, 2023 10-K 2024-02-26
Q1 2023 $47.4K $19.2K -$22.5K -53.9% Feb 1, 2023 Apr 30, 2023 10-Q 2024-11-13
Q4 2022 $69.9K $20.1K -$9.46K -32% Nov 1, 2022 Jan 31, 2023 10-Q 2024-09-05
Q3 2022 $79.3K $20.1K -$21.1K -51.2% Aug 1, 2022 Oct 31, 2022 10-Q 2024-08-09
Q2 2022 $100K -$12.1K -$265K -105% May 1, 2022 Jul 31, 2022 10-K 2024-02-26
Q1 2022 $365K $41.7K -$53.7K -56.2% Feb 1, 2022 Apr 30, 2022 10-Q 2024-01-09
Q4 2021 $419K $29.5K -$60.5K -67.2% Nov 1, 2021 Jan 31, 2022 10-Q 2024-01-08
Q3 2021 $479K $41.2K -$72.6K -63.8% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-22
Q2 2021 $552K $253K +$121K +92% May 1, 2021 Jul 31, 2021 10-K 2022-11-25
Q1 2021 $431K $95.4K -$35.7K -27.2% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-16
Q4 2020 $466K $90K -$22.8K -20.2% Nov 1, 2020 Jan 31, 2021 10-Q 2022-05-16
Q3 2020 $489K $114K +$1.59K +1.41% Aug 1, 2020 Oct 31, 2020 10-Q 2022-05-16
Q2 2020 $488K $132K +$2.05K +1.59% May 1, 2020 Jul 31, 2020 10-K 2022-03-31
Q1 2020 $486K $131K -$69.3K -34.6% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-22
Q4 2019 $555K $113K +$133K Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-29
Q3 2019 $422K $112K +$118K Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-17
Q2 2019 $304K $129K +$320K May 1, 2019 Jul 31, 2019 10-K 2020-11-04
Q1 2019 -$16.2K $200K +$172K +598% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-22
Q4 2018 -$188K -$20.5K -$51.4K -167% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-23
Q3 2018 -$137K -$5.77K -$34.8K -120% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-23
Q2 2018 -$102K -$190K May 1, 2018 Jul 31, 2018 10-K/A 2019-11-18
Q1 2018 $28.7K Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 $30.9K Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-15
Q3 2017 $29K Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-19
Q1 2014 $3.02K $2.09K +$1.34K +179% Feb 1, 2014 Apr 30, 2014 10-Q 2014-06-12
Q4 2013 $1.68K $1.09K +$843 +337% Nov 1, 2013 Jan 31, 2014 10-Q 2014-06-12
Q3 2013 $833 $833 +$833 Aug 1, 2013 Oct 31, 2013 10-Q 2014-06-11
Q2 2013 $0 -$1K -$1.3K -433% May 1, 2013 Jul 31, 2013 10-K 2014-06-09
Q1 2013 $1.3K $750 +$450 +150% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-12
Q4 2012 $850 $250 -$50 -16.7% Nov 1, 2012 Jan 31, 2013 10-Q 2014-06-12
Q3 2012 $900 $0 -$300 -100% Aug 1, 2012 Oct 31, 2012 10-Q 2014-06-11
Q2 2012 $1.2K $300 -$1.79K -85.7% May 1, 2012 Jul 31, 2012 10-K 2014-06-09
Q1 2012 $2.99K $300 +$600 Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-11
Q4 2011 $2.39K $300 +$596 Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-21
Q3 2011 $1.8K $300 +$596 Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 $1.2K $2.09K May 1, 2011 Jul 31, 2011 10-K 2012-11-13
Q1 2011 -$300 Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$296 Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q3 2010 -$296 Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.